Resmed Inc at William Blair Growth Stock Conference (Virtual) Transcript
Hey, good afternoon, everyone. My name is Margaret Kaczor. I am the research analyst here at William Blair & Company who covers ResMed. I am required to inform you that you can obtain a complete list of research disclosures or potential conflicts of interest at williamblair.com. Now because the conference is, unfortunately, still virtual this year, we are going to keep this to a fireside chat.
So we're going to go for some of the company basics, some recent updates, as well as some more future outlook details. There is a way to send us some questions online. So feel free to submit those, and I will certainly ask them as they come up. But with that, we're very pleased to have Rob Douglas, President and COO of ResMed with us. Rob, thanks for joining us.
Yes. Thanks, Margaret. Just by way of quick introduction, we announced our results about a month ago now. So that's where we are. Basically, that was a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |